ICU Medical (NASDAQ:ICUI) Downgraded by StockNews.com to Hold

ICU Medical (NASDAQ:ICUI) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

A number of other research analysts have also recently issued reports on ICUI. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a report on Wednesday, December 11th. Raymond James set a $97.00 target price on ICU Medical in a research note on Wednesday, March 12th. Two research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and a consensus target price of $168.67.

ICU Medical Stock Down 2.9 %

Shares of ICUI stock opened at $140.16 on Thursday. The stock has a market cap of $3.44 billion, a P/E ratio of -30.67 and a beta of 0.73. The stock has a fifty day moving average price of $154.42 and a 200 day moving average price of $163.84. ICU Medical has a one year low of $93.36 and a one year high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Insider Transactions at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 6.70% of the company’s stock.

Hedge Funds Weigh In On ICU Medical

Several institutional investors and hedge funds have recently modified their holdings of the business. Arizona State Retirement System boosted its holdings in shares of ICU Medical by 1.0% in the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier’s stock valued at $1,044,000 after buying an additional 65 shares during the period. Huntington National Bank raised its stake in shares of ICU Medical by 6.2% in the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier’s stock valued at $218,000 after purchasing an additional 82 shares during the period. Equitable Trust Co. raised its position in ICU Medical by 1.6% in the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock valued at $822,000 after buying an additional 84 shares during the last quarter. LPL Financial LLC lifted its stake in ICU Medical by 2.0% in the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier’s stock valued at $747,000 after acquiring an additional 93 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its position in ICU Medical by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier’s stock worth $4,051,000 after acquiring an additional 136 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.